APA (7th ed.) Citation

M, B., N, B., A, R., L, A., C, D., M, G., . . . S, G. (2025). ARI0003: Co-transduced CD19/BCMA dual-targeting CAR-T cells for the treatment of non-Hodgkin lymphoma. Molecular therapy : the journal of the American Society of Gene Therapy, 33(1), 317. https://doi.org/10.1016/j.ymthe.2024.11.028

Chicago Style (17th ed.) Citation

M, Bachiller, et al. "ARI0003: Co-transduced CD19/BCMA Dual-targeting CAR-T Cells for the Treatment of Non-Hodgkin Lymphoma." Molecular Therapy : The Journal of the American Society of Gene Therapy 33, no. 1 (2025): 317. https://doi.org/10.1016/j.ymthe.2024.11.028.

MLA (9th ed.) Citation

M, Bachiller, et al. "ARI0003: Co-transduced CD19/BCMA Dual-targeting CAR-T Cells for the Treatment of Non-Hodgkin Lymphoma." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 33, no. 1, 2025, p. 317, https://doi.org/10.1016/j.ymthe.2024.11.028.